SOCIEDAD
Comité Científico
Comisión de Proteínas
Enlaces de interés
ACTUALIZACIÓN: 30/12/2010
Recursos en webs, bibliografía, guías y bases de datos.
- NACB Guidelines for the Use of Tumor Markers. Clin Chem 2008; 54 (11): 1935-9.
http://www.aacc.org/sitecollectiondocuments/nacb/lmpg/tumor/chp3k_gammopathies.pdf http://www.clinchem.org/cgi/reprint/54/11/1935.pdf) -
- NACB Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. [Clin Chem 2007; 53 (4): 552-574.]
- NACB and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes. [Clin Chem 2007; 53 (4): 547-551.]
- NACB Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure. [Clin Chem 2007; 53 (4): 547-551.]
- Guidelines for the Diagnosis and Management of α1-Antitrypsin Deficiency. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). [Arch Broconeumol 2006; 42 (12): 645-659.]
- French Guidelines: Microalbuminuria and urinary albumin excretion. [Ann Biol Clin 2008; 66 (3): 277-284.]
- UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines fro the investigation of newly detected M- Proteins and the management of monoclonal gammopathy of undetermined significance. BJH 2009; 17: 22-42.
- Dispenzieri A, Kyle R, Merlini G et al. International Myeloma Working Group Guidelines for serum free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23: 215-24
- Guidelines for the analysis of Bence Jones Protein. Clin Chem Lab Meed 2003; 41 (3): 338-46
